Deleterious effects of skin freezing contribute to variable outcomes of the predictive drug permeation studies using hydrophilic molecules.
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Rawad
R
Abdayem
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Laurène
L
Roussel
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Nicolas
N
Zaman
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Fabrice
F
Pirot
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Elodie
E
Gilbert
EA4169 "Fundamental, clinical and therapeutic aspects of the skin barrier function", University of Lyon 1, Lyon, France.
Marek
M
Haftek
D000818:Animals; D004817:Epidermis / Q000378:metabolism / Q000648:ultrastructure; D005110:Extracellular Space / Q000378:metabolism; D005615:Freezing; D057927:Hydrophobic and Hydrophilic Interactions; D066298:In Vitro Techniques; D010539:Permeability; D012867:Skin / Q000378:metabolism* / Q000648:ultrastructure; D012869:Skin Absorption / Q000502:physiology*; D013552:Swine
ex vivo permeation tests; skin permeability barrier; stratum corneum; ultrastructure